Chondroitin sulfate inhibits lipopolysaccharide-induced inflammation in rat astrocytes by preventing nuclear factor kappa B activation

Neuroscience

Volumn 167, Issue 3, 2010, Pages 872-879

  Canas N ^a,b   Gorina, R ^c   Planas, A M ^c   Verges J ^d   Montell, E ^d   Garcia A G ^a,b,e   Lopez M G ^a,b  

^a INSTITUTO TEÓFILO HERNANDO   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^d BIOIBERICA SA   (Spain)

^e HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Astrocytes; Chondroitin sulfate; Glucosaminoglycan; Lipopolysaccharide; NFK green B

Indexed keywords

CHONDROITIN SULFATE; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; JANUS KINASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; STAT PROTEIN; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; GENE INDUCTION; GENE TRANSLOCATION; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOMODULATION; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 77951297156     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.02.069     Document Type: Article

References (46)

1. Allan S.M., Rothwell N.J. Cytokines and acute neurodegeneration. Nat Rev Neurosci 2001, 2:734-744.
2. Campo G.M., Avenoso A., Campo S., D'Ascola A., Traina P., Calatroni A. Chondroitin-4-sulphate inhibits NF-kB translocation and caspase activation in collagen-induced arthritis in mice. Osteoarthr Cartil 2008, 16:1474-1483.
3. Campo G.M., Avenoso A., Campo S., D'Ascola A., Traina P., Sama D., Calatroni A. Purified human plasma glycosaminoglycans reduced NF-kappaB activation, pro-inflammatory cytokine production and apoptosis in LPS-treated chondrocytes. Innate Immun 2008, 14:233-246.
4. Campo G.M., Avenoso A., Campo S., Traina P., D'Ascola A., Calatroni A. Glycosaminoglycans reduced inflammatory response by modulating toll-like receptor-4 in LPS-stimulated chondrocytes. Arch Biochem Biophys 2009, 491:7-15.
5. Canas N., Valero T., Villarroya M., Montell E., Verges J., Garcia A.G., Lopez M.G. Chondroitin sulfate protects SH-SY5Y cells from oxidative stress by inducing heme oxygenase-1 via phosphatidylinositol 3-kinase/Akt. J Pharmacol Exp Ther 2007, 323:946-953.
6. Chen C.H., Sheu M.T., Chen T.F., Wang Y.C., Hou W.C., Liu D.Z., Chung T.C., Liang Y.C. Suppression of endotoxin-induced proinflammatory responses by citrus pectin through blocking LPS signaling pathways. Biochem Pharmacol 2006, 72:1001-1009.
7. Cheng Q., Cant C.A., Moll T., Hofer-Warbinek R., Wagner E., Birnstiel M.L., Bach F.H., de Martin R. NK-kappa B subunit-specific regulation of the I kappa B alpha promoter. J Biol Chem 1994, 269:13551-13557.
8. Choi I.Y., Jung H.S., Kim H.R., Lee E.J., Lee E.H., Shin T.Y., Kim H.M., Hong S.H. OK205 regulates production of inflammatory cytokines in HMC-1 cells. Biol Pharm Bull 2004, 27:1871-1874.
9. Chou M.M., Vergnolle N., McDougall J.J., Wallace J.L., Marty S., Teskey V., Buret A.G. Effects of chondroitin and glucosamine sulfate in a dietary bar formulation on inflammation, interleukin-1beta, matrix metalloprotease-9, and cartilage damage in arthritis. Exp Biol Med (Maywood) 2005, 230:255-262.
10. Doyle S.L., O'Neill L.A. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem Pharmacol 2006, 72:1102-1113.
11. Farina C., Aloisi F., Meinl E. Astrocytes are active players in cerebral innate immunity. Trends Immunol 2007, 28:138-145.
12. Farooqui A.A., Horrocks L.A., Farooqui T. Modulation of inflammation in brain: a matter of fat. J Neurochem 2007, 101:577-599.
13. Gloire G., Legrand-Poels S., Piette J. NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol 2006, 72:1493-1505.
14. Goodwin D.C., Landino L.M., Marnett L.J. Effects of nitric oxide and nitric oxide-derived species on prostaglandin endoperoxide synthase and prostaglandin biosynthesis. FASEB J 1999, 13:1121-1136.
15. Griffin W.S. Perispinal etanercept: potential as an Alzheimer therapeutic. J Neuroinflammation 2008, 5:3.
16. Hanisch U.K. Microglia as a source and target of cytokines. Glia 2002, 40:140-155.
17. Hirst W.D., Young K.A., Newton R., Allport V.C., Marriott D.R., Wilkin G.P. Expression of COX-2 by normal and reactive astrocytes in the adult rat central nervous system. Mol Cell Neurosci 1999, 13:57-68.
18. Kaltschmidt B., Sparna T., Kaltschmidt C. Activation of NF-kappa B by reactive oxygen intermediates in the nervous system. Antioxid Redox Signal 1999, 1:129-144.
19. Kaushal V., Schlichter L.C. Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. J Neurosci 2008, 28:2221-2230.
20. Kohno K., Miyake M., Sano O., Tanaka-Kataoka M., Yamamoto S., Koya-Miyata S., Arai N., Fujii M., Watanabe H., Ushio S., Iwaki K., Fukuda S. Anti-inflammatory and immunomodulatory properties of 2-amino-3H-phenoxazin-3-one. Biol Pharm Bull 2008, 31:1938-1945.
21. Lai P.F., Mohamed F., Monge J.C., Stewart D.J. Downregulation of eNOS mRNA expression by TNFalpha: identification and functional characterization of RNA-protein interactions in the 3'UTR. Cardiovasc Res 2003, 59:160-168.
22. Mollace V., Muscoli C., Masini E., Cuzzocrea S., Salvemini D. Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol Rev 2005, 57:217-252.
23. Mrak R.E., Griffin W.S. Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging 2005, 26:349-354.
24. Okamoto M., Mori S., Endo H. A protective action of chondroitin sulfate proteoglycans against neuronal cell death induced by glutamate. Brain Res 1994, 637:57-67.
25. Okamoto M., Mori S., Ichimura M., Endo H. Chondroitin sulfate proteoglycans protect cultured rat's cortical and hippocampal neurons from delayed cell death induced by excitatory amino acids. Neurosci Lett 1994, 172:51-54.
26. Quinlan K.L., Naik S.M., Cannon G., Armstrong C.A., Bunnett N.W., Ansel J.C., Caughman S.W. Substance P activates coincident NF-AT- and NF-kappa B-dependent adhesion molecule gene expression in microvascular endothelial cells through intracellular calcium mobilization. J Immunol 1999, 163:5656-5665.
27. Rawlings J.S., Rosler K.M., Harrison D.A. The JAK/STAT signaling pathway. J Cell Sci 2004, 117:1281-1283.
28. Rolls A., Cahalon L., Bakalash S., Avidan H., Lider O., Schwartz M. A sulfated disaccharide derived from chondroitin sulfate proteoglycan protects against inflammation-associated neurodegeneration. FASEB J 2006, 20:547-549.
29. Salminen A., Ojala J., Kauppinen A., Kaarniranta K., Suuronen T. Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors. Prog Neurobiol 2009, 87:181-194.
30. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci U S A 1993, 90:7240-7244.
31. Sato Y., Nakanishi K., Tokita Y., Kakizawa H., Ida M., Maeda H., Matsui F., Aono S., Saito A., Kuroda Y., Hayakawa M., Kojima S., Oohira A. A highly sulfated chondroitin sulfate preparation, CS-E, prevents excitatory amino acid-induced neuronal cell death. J Neurochem 2008, 104:1565-1576.
32. Sethi G., Sung B., Aggarwal B.B. Nuclear factor-kappaB activation: from bench to bedside. Exp Biol Med (Maywood) 2008, 233:21-31.
33. Shah I.M., Macrae I.M., Di Napoli M. Neuroinflammation and neuroprotective strategies in acute ischaemic stroke-from bench to bedside. Curr Mol Med 2009, 9:336-354.
34. Sriram K., O'Callaghan J.P. Divergent roles for tumor necrosis factor-alpha in the brain. J Neuroimmune Pharmacol 2007, 2:140-153.
35. Strokin M., Sergeeva M., Reiser G. Prostaglandin synthesis in rat brain astrocytes is under the control of the n-3 docosahexaenoic acid, released by group VIB calcium-independent phospholipase A2. J Neurochem 2007, 102:1771-1782.
36. Szabo C., Thiemermann C. Invited opinion: role of nitric oxide in hemorrhagic, traumatic, and anaphylactic shock and thermal injury. Shock 1994, 2:145-155.
37. Takei Y., Laskey R. Interpreting crosstalk between TNF-alpha and NGF:potential implications for disease. Trends Mol Med 2008, 14:381-388.
38. Takuma K., Baba A., Matsuda T. Astrocyte apoptosis: implications for neuroprotection. Prog Neurobiol 2004, 72:111-127.
39. Uno K., Iuchi Y., Fujii J., Sugata H., Iijima K., Kato K., Shimosegawa T., Yoshimura T. In vivo study on cross talk between inducible nitric-oxide synthase and cyclooxygenase in rat gastric mucosa: effect of cyclooxygenase activity on nitric oxide production. J Pharmacol Exp Ther 2004, 309:995-1002.
40. Van Eldik L.J., Thompson W.L., Ralay Ranaivo H., Behanna H.A., Martin Watterson D. Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: function-based and target-based discovery approaches. Int Rev Neurobiol 2007, 82:277-296.
41. Vane J.R., Mitchell J.A., Appleton I., Tomlinson A., Bishop-bailey D., Croxtall J., Willoughby D.A. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci U S A 1994, 91:2046-2050.
42. Wu K.K. Control of cyclooxygenase-2 transcriptional activation by pro-inflammatory mediators. Prostaglandins Leukot Essent Fatty Acids 2005, 72:89-93.
43. 2 production in astrocytes: regulation by cytokines, extracellular ATP, and oxidative agents. Prostaglandins Leukot Essent Fatty Acids 2003, 69:437-448.
44. Yermakova A., O'Banion M.K. Cyclooxygenases in the central nervous system: implications for treatment of neurological disorders. Curr Pharm Des 2000, 6:1755-1776.
45. Zamora R., Vodovotz Y., Billiar T.R. Inducible nitric oxide synthase and inflammatory diseases. Mol Med 2000, 6:347-373.
46. Zielasek J., Hartung H.P. Molecular mechanisms of microglial activation. Adv Neuroimmunol 1996, 6. 191-122.